Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | Starlite/ChEMBL | References |
Rattus norvegicus | Dehydrogenase/reductase SDR family member 9 | Starlite/ChEMBL | References |
Homo sapiens | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Onchocerca volvulus | Krev interaction trapped protein 1 homolog | Dehydrogenase/reductase SDR family member 9 | 319 aa | 293 aa | 33.1 % |
Loa Loa (eye worm) | hypothetical protein | Dehydrogenase/reductase SDR family member 9 | 319 aa | 300 aa | 38.3 % |
Onchocerca volvulus | Dehydrogenase/reductase SDR family member 9 | 319 aa | 294 aa | 34.7 % | |
Dictyostelium discoideum | short-chain dehydrogenase/reductase family protein | Dehydrogenase/reductase SDR family member 9 | 319 aa | 273 aa | 24.9 % |
Dictyostelium discoideum | short-chain dehydrogenase/reductase family protein | Dehydrogenase/reductase SDR family member 9 | 319 aa | 275 aa | 26.6 % |
Onchocerca volvulus | Dehydrogenase/reductase SDR family member 9 | 319 aa | 297 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | Chorion peroxidase homolog | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 1 | 1 |
Brugia malayi | Animal haem peroxidase family protein | 0.0063 | 1 | 1 |
Onchocerca volvulus | 0.0063 | 1 | 1 | |
Loa Loa (eye worm) | blistered cuticle protein 3 | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | oxidoreductase | 0.0054 | 0.3206 | 0.3206 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 1 | 1 |
Mycobacterium ulcerans | dehydrogenase/decarboxylase protein | 0.0054 | 0.3206 | 0.5 |
Brugia malayi | Animal haem peroxidase family protein | 0.0063 | 1 | 1 |
Brugia malayi | Peroxidasin | 0.0063 | 1 | 1 |
Onchocerca volvulus | Peroxidase homolog | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 1 | 1 |
Brugia malayi | Animal haem peroxidase family protein | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 1 | 1 |
Onchocerca volvulus | Peroxidasin homolog | 0.0063 | 1 | 1 |
Schistosoma mansoni | peroxidasin | 0.0063 | 1 | 0.5 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 1 | 1 |
Schistosoma mansoni | peroxidasin | 0.0063 | 1 | 0.5 |
Brugia malayi | Blistered cuticle protein 3 | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 1 | 1 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0054 | 0.3206 | 0.5 |
Toxoplasma gondii | oxidoreductase, short chain dehydrogenase/reductase family protein | 0.0054 | 0.3206 | 0.5 |
Brugia malayi | Animal haem peroxidase family protein | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0063 | 1 | 1 |
Brugia malayi | Animal haem peroxidase family protein | 0.0063 | 1 | 1 |
Onchocerca volvulus | 0.0063 | 1 | 1 | |
Onchocerca volvulus | Peroxidasin homolog | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 1 | 1 |
Onchocerca volvulus | Dual oxidase homolog | 0.0063 | 1 | 1 |
Echinococcus multilocularis | peroxidasin | 0.0063 | 1 | 0.5 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0063 | 1 | 1 |
Onchocerca volvulus | Peroxidase homolog | 0.0063 | 1 | 1 |
Echinococcus granulosus | peroxidasin | 0.0063 | 1 | 0.5 |
Onchocerca volvulus | 0.0063 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 42.4 % | Antiinflammatory activity against carrageenan-induced paw oedema in Sprague-Dawley rat assessed as swelling thickness at 70 mg/kg, po after 3 hrs | ChEMBL. | 17517512 |
Activity (functional) | = 44.9 % | Antiinflammatory activity against carrageenan-induced paw oedema in Sprague-Dawley rat assessed as swelling thickness at 70 mg/kg, po after 4 hrs | ChEMBL. | 17517512 |
IC50 (binding) | = 6.2 uM | Inhibition of COX2 in human whole blood after 15 mins | ChEMBL. | 17517512 |
IC50 (binding) | = 6.2 uM | Inhibition of COX2 in human whole blood after 15 mins | ChEMBL. | 17517512 |
IC50 (binding) | = 18 uM | Inhibition of rat liver 3alphaHSD assessed as 5beta-dihydrocortisone reduction | ChEMBL. | 17517512 |
IC50 (binding) | = 18 uM | Inhibition of rat liver 3alphaHSD assessed as 5beta-dihydrocortisone reduction | ChEMBL. | 17517512 |
IC50 (binding) | = 19.8 uM | Inhibition of COX1 in human whole blood after 15 mins | ChEMBL. | 17517512 |
IC50 (binding) | = 19.8 uM | Inhibition of COX1 in human whole blood after 15 mins | ChEMBL. | 17517512 |
Inhibition (functional) | = 23.2 % | Antiinflammatory activity in Sprague-Dawley rat assessed as inhibition of carrageenan-induced paw oedema at 70 mg/kg, po after 3 hrs relative to control | ChEMBL. | 17517512 |
Inhibition (functional) | = 23.4 % | Antiinflammatory activity in Sprague-Dawley rat assessed as inhibition of carrageenan-induced paw oedema at 70 mg/kg, po after 4 hrs relative to control | ChEMBL. | 17517512 |
Inhibition (binding) | = 71.3 % | Inhibition of rat liver 3alphaHSD assessed as 5beta-dihydrocortisone reduction at 500 uM | ChEMBL. | 17517512 |
Inhibition (binding) | = 71.3 % | Inhibition of rat liver 3alphaHSD assessed as 5beta-dihydrocortisone reduction at 500 uM | ChEMBL. | 17517512 |
Ratio IC50 (binding) | = 3.2 | Selectivity for human COX2 over human COX1 | ChEMBL. | 17517512 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.